Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 31 of 31 entries
Sorted by: Best Match Show Resources per page
Implementing and Sustaining Evidence Based Practice Through a Nursing Journal Club.

Applied nursing research : ANR

Gardner K, Kanaskie ML, Knehans AC, Salisbury S, Doheny KK, Schirm V.
PMID: 27397832
Appl Nurs Res. 2016 Aug;31:139-45. doi: 10.1016/j.apnr.2016.02.001. Epub 2016 Feb 21.

BACKGROUND: The outcomes based emphasis in nursing and health care delivery requires identification of best available evidence in order to produce quality, safe, and effective patient care. Finding, critiquing, and ultimately implementing the best available evidence for practice is...

Cite
Gardner K, Kanaskie ML, Knehans AC, et al. Implementing and Sustaining Evidence Based Practice Through a Nursing Journal Club. Appl Nurs Res. 2016;31:139-45doi: 10.1016/j.apnr.2016.02.001.
Gardner, K., Kanaskie, M. L., Knehans, A. C., Salisbury, S., Doheny, K. K., & Schirm, V. (2016). Implementing and Sustaining Evidence Based Practice Through a Nursing Journal Club. Applied nursing research : ANR, 31139-45. https://doi.org/10.1016/j.apnr.2016.02.001
Gardner, Kevin, et al. "Implementing and Sustaining Evidence Based Practice Through a Nursing Journal Club." Applied nursing research : ANR vol. 31 (2016): 139-45. doi: https://doi.org/10.1016/j.apnr.2016.02.001
Gardner K, Kanaskie ML, Knehans AC, Salisbury S, Doheny KK, Schirm V. Implementing and Sustaining Evidence Based Practice Through a Nursing Journal Club. Appl Nurs Res. 2016 Aug;31:139-45. doi: 10.1016/j.apnr.2016.02.001. Epub 2016 Feb 21. PMID: 27397832.
Copy Download .nbib Format: NLM
Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer.

Journal of the National Cancer Institute

Darst BF, Dadaev T, Saunders E, Sheng X, Wan P, Pooler L, Xia LY, Chanock S, Berndt SI, Gapstur SM, Stevens V, Albanes D, Weinstein SJ, Gnanapragasam V, Giles GG, Nguyen-Dumont T, Milne RL, Pomerantz M, Schmidt JA, Mucci L, Catalona WJ, Hetrick KN, Doheny KF, MacInnis RJ, Southey MC, Eeles RA, Wiklund F, Kote-Jarai Z, Conti DV, Haiman CA.
PMID: 32853339
J Natl Cancer Inst. 2021 May 04;113(5):616-625. doi: 10.1093/jnci/djaa132.

BACKGROUND: There is an urgent need to identify factors specifically associated with aggressive prostate cancer (PCa) risk. We investigated whether rare pathogenic, likely pathogenic, or deleterious (P/LP/D) germline variants in DNA repair genes are associated with aggressive PCa risk...

Cite
Darst BF, Dadaev T, Saunders E, et al. Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer. J Natl Cancer Inst. 2021;113(5):616-625doi: 10.1093/jnci/djaa132.
Darst, B. F., Dadaev, T., Saunders, E., Sheng, X., Wan, P., Pooler, L., Xia, L. Y., Chanock, S., Berndt, S. I., Gapstur, S. M., Stevens, V., Albanes, D., Weinstein, S. J., Gnanapragasam, V., Giles, G. G., Nguyen-Dumont, T., Milne, R. L., Pomerantz, M., Schmidt, J. A., Mucci, L., Catalona, W. J., Hetrick, K. N., Doheny, K. F., MacInnis, R. J., Southey, M. C., Eeles, R. A., Wiklund, F., Kote-Jarai, Z., Conti, D. V., & Haiman, C. A. (2021). Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer. Journal of the National Cancer Institute, 113(5), 616-625. https://doi.org/10.1093/jnci/djaa132
Darst, Burcu F, et al. "Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer." Journal of the National Cancer Institute vol. 113,5 (2021): 616-625. doi: https://doi.org/10.1093/jnci/djaa132
Darst BF, Dadaev T, Saunders E, Sheng X, Wan P, Pooler L, Xia LY, Chanock S, Berndt SI, Gapstur SM, Stevens V, Albanes D, Weinstein SJ, Gnanapragasam V, Giles GG, Nguyen-Dumont T, Milne RL, Pomerantz M, Schmidt JA, Mucci L, Catalona WJ, Hetrick KN, Doheny KF, MacInnis RJ, Southey MC, Eeles RA, Wiklund F, Kote-Jarai Z, Conti DV, Haiman CA. Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer. J Natl Cancer Inst. 2021 May 04;113(5):616-625. doi: 10.1093/jnci/djaa132. PMID: 32853339; PMCID: PMC8599772.
Copy Download .nbib Format: NLM
TrkA Interacts with and Phosphorylates STAT3 to Enhance Gene Transcription and Promote Breast Cancer Stem Cells in Triple-Negative and HER2-Enriched Breast Cancers.

Cancers

Regua AT, Aguayo NR, Jalboush SA, Doheny DL, Manore SG, Zhu D, Wong GL, Arrigo A, Wagner CJ, Yu Y, Thomas A, Chan MD, Ruiz J, Jin G, Strowd R, Sun P, Lin J, Lo HW.
PMID: 34066153
Cancers (Basel). 2021 May 12;13(10). doi: 10.3390/cancers13102340.

JAK2-STAT3 and TrkA signaling pathways have been separately implicated in aggressive breast cancers; however, whether they are co-activated or undergo functional interaction has not been thoroughly investigated. Herein we report, for the first time that STAT3 and TrkA are...

Cite
Regua AT, Aguayo NR, Jalboush SA, et al. TrkA Interacts with and Phosphorylates STAT3 to Enhance Gene Transcription and Promote Breast Cancer Stem Cells in Triple-Negative and HER2-Enriched Breast Cancers. Cancers (Basel). 2021;13(10)doi: 10.3390/cancers13102340.
Regua, A. T., Aguayo, N. R., Jalboush, S. A., Doheny, D. L., Manore, S. G., Zhu, D., Wong, G. L., Arrigo, A., Wagner, C. J., Yu, Y., Thomas, A., Chan, M. D., Ruiz, J., Jin, G., Strowd, R., Sun, P., Lin, J., & Lo, H. W. (2021). TrkA Interacts with and Phosphorylates STAT3 to Enhance Gene Transcription and Promote Breast Cancer Stem Cells in Triple-Negative and HER2-Enriched Breast Cancers. Cancers, 13(10), . https://doi.org/10.3390/cancers13102340
Regua, Angelina T, et al. "TrkA Interacts with and Phosphorylates STAT3 to Enhance Gene Transcription and Promote Breast Cancer Stem Cells in Triple-Negative and HER2-Enriched Breast Cancers." Cancers vol. 13,10 (2021). doi: https://doi.org/10.3390/cancers13102340
Regua AT, Aguayo NR, Jalboush SA, Doheny DL, Manore SG, Zhu D, Wong GL, Arrigo A, Wagner CJ, Yu Y, Thomas A, Chan MD, Ruiz J, Jin G, Strowd R, Sun P, Lin J, Lo HW. TrkA Interacts with and Phosphorylates STAT3 to Enhance Gene Transcription and Promote Breast Cancer Stem Cells in Triple-Negative and HER2-Enriched Breast Cancers. Cancers (Basel). 2021 May 12;13(10). doi: 10.3390/cancers13102340. PMID: 34066153; PMCID: PMC8150921.
Copy Download .nbib Format: NLM
Postnatal Determination of Sex.

Science (New York, N.Y.)

Doheny JJ.
PMID: 17835230
Science. 1956 Aug 10;124(3215):277. doi: 10.1126/science.124.3215.277.

No abstract available.

Cite
Doheny JJ. Postnatal Determination of Sex. Science. 1956;124(3215):277doi: 10.1126/science.124.3215.277.
Doheny, J. J. (1956). Postnatal Determination of Sex. Science (New York, N.Y.), 124(3215), 277. https://doi.org/10.1126/science.124.3215.277
Doheny, J J. "Postnatal Determination of Sex." Science (New York, N.Y.) vol. 124,3215 (1956): 277. doi: https://doi.org/10.1126/science.124.3215.277
Doheny JJ. Postnatal Determination of Sex. Science. 1956 Aug 10;124(3215):277. doi: 10.1126/science.124.3215.277. PMID: 17835230.
Copy Download .nbib Format: NLM
Incidental genetic findings in randomized clinical trials: recommendations from the Genomics and Randomized Trials Network (GARNET).

Genome medicine

Bookman EB, Din-Lovinescu C, Worrall BB, Manolio TA, Bennett SN, Laurie C, Mirel DB, Doheny KF, Anderson GL, Wehr K, Weinshilboum R, Chen DT.
PMID: 23363732
Genome Med. 2013 Jan 30;5(1):7. doi: 10.1186/gm411. eCollection 2013.

Recommendations and guidance on how to handle the return of genetic results to patients have offered limited insight into how to approach incidental genetic findings in the context of clinical trials. This paper provides the Genomics and Randomized Trials...

Cite
Bookman EB, Din-Lovinescu C, Worrall BB, et al. Incidental genetic findings in randomized clinical trials: recommendations from the Genomics and Randomized Trials Network (GARNET). Genome Med. 2013;5(1):7doi: 10.1186/gm411.
Bookman, E. B., Din-Lovinescu, C., Worrall, B. B., Manolio, T. A., Bennett, S. N., Laurie, C., Mirel, D. B., Doheny, K. F., Anderson, G. L., Wehr, K., Weinshilboum, R., & Chen, D. T. (2013). Incidental genetic findings in randomized clinical trials: recommendations from the Genomics and Randomized Trials Network (GARNET). Genome medicine, 5(1), 7. https://doi.org/10.1186/gm411
Bookman, Ebony B, et al. "Incidental genetic findings in randomized clinical trials: recommendations from the Genomics and Randomized Trials Network (GARNET)." Genome medicine vol. 5,1 (2013): 7. doi: https://doi.org/10.1186/gm411
Bookman EB, Din-Lovinescu C, Worrall BB, Manolio TA, Bennett SN, Laurie C, Mirel DB, Doheny KF, Anderson GL, Wehr K, Weinshilboum R, Chen DT. Incidental genetic findings in randomized clinical trials: recommendations from the Genomics and Randomized Trials Network (GARNET). Genome Med. 2013 Jan 30;5(1):7. doi: 10.1186/gm411. eCollection 2013. PMID: 23363732; PMCID: PMC3706830.
Copy Download .nbib Format: NLM
Through-Space Intervalence Charge Transfer as a Mechanism for Charge Delocalization in Metal-Organic Frameworks.

Journal of the American Chemical Society

Hua C, Doheny PW, Ding B, Chan B, Yu M, Kepert CJ, D'Alessandro DM.
PMID: 29727176
J Am Chem Soc. 2018 May 30;140(21):6622-6630. doi: 10.1021/jacs.8b02638. Epub 2018 May 18.

Understanding the nature of charge transfer mechanisms in 3-dimensional metal-organic frameworks (MOFs) is an important goal owing to the possibility of harnessing this knowledge to design electroactive and conductive frameworks. These materials have been proposed as the basis for...

Cite
Hua C, Doheny PW, Ding B, et al. Through-Space Intervalence Charge Transfer as a Mechanism for Charge Delocalization in Metal-Organic Frameworks. J Am Chem Soc. 2018;140(21):6622-6630doi: 10.1021/jacs.8b02638.
Hua, C., Doheny, P. W., Ding, B., Chan, B., Yu, M., Kepert, C. J., & D'Alessandro, D. M. (2018). Through-Space Intervalence Charge Transfer as a Mechanism for Charge Delocalization in Metal-Organic Frameworks. Journal of the American Chemical Society, 140(21), 6622-6630. https://doi.org/10.1021/jacs.8b02638
Hua, Carol, et al. "Through-Space Intervalence Charge Transfer as a Mechanism for Charge Delocalization in Metal-Organic Frameworks." Journal of the American Chemical Society vol. 140,21 (2018): 6622-6630. doi: https://doi.org/10.1021/jacs.8b02638
Hua C, Doheny PW, Ding B, Chan B, Yu M, Kepert CJ, D'Alessandro DM. Through-Space Intervalence Charge Transfer as a Mechanism for Charge Delocalization in Metal-Organic Frameworks. J Am Chem Soc. 2018 May 30;140(21):6622-6630. doi: 10.1021/jacs.8b02638. Epub 2018 May 18. PMID: 29727176.
Copy Download .nbib Format: NLM
Author Correction: Deficiency of TET3 leads to a genome-wide DNA hypermethylation episignature in human whole blood.

NPJ genomic medicine

Levy MA, Beck DB, Metcalfe K, Douzgou S, Sithambaram S, Cottrell T, Ansar M, Kerkhof J, Mignot C, Nougues MC, Keren B, Moore HW, Oegema R, Giltay JC, Simon M, van Jaarsveld RH, Bos J, van Haelst M, Motazacker MM, Boon EMJ, Santen GWE, Ruivenkamp CAL, Alders M, Luperchio TR, Boukas L, Ramsey K, Narayanan V, Schaefer GB, Bonasio R, Doheny KF, Stevenson RE, Banka S, Sadikovic B, Fahrner JA.
PMID: 34819528
NPJ Genom Med. 2021 Nov 24;6(1):100. doi: 10.1038/s41525-021-00269-7.

No abstract available.

Cite
Levy MA, Beck DB, Metcalfe K, et al. Author Correction: Deficiency of TET3 leads to a genome-wide DNA hypermethylation episignature in human whole blood. NPJ Genom Med. 2021;6(1):100doi: 10.1038/s41525-021-00269-7.
Levy, M. A., Beck, D. B., Metcalfe, K., Douzgou, S., Sithambaram, S., Cottrell, T., Ansar, M., Kerkhof, J., Mignot, C., Nougues, M. C., Keren, B., Moore, H. W., Oegema, R., Giltay, J. C., Simon, M., van Jaarsveld, R. H., Bos, J., van Haelst, M., Motazacker, M. M., Boon, E. M. J., Santen, G. W. E., Ruivenkamp, C. A. L., Alders, M., Luperchio, T. R., Boukas, L., Ramsey, K., Narayanan, V., Schaefer, G. B., Bonasio, R., Doheny, K. F., Stevenson, R. E., Banka, S., Sadikovic, B., & Fahrner, J. A. (2021). Author Correction: Deficiency of TET3 leads to a genome-wide DNA hypermethylation episignature in human whole blood. NPJ genomic medicine, 6(1), 100. https://doi.org/10.1038/s41525-021-00269-7
Levy, Michael A, et al. "Author Correction: Deficiency of TET3 leads to a genome-wide DNA hypermethylation episignature in human whole blood." NPJ genomic medicine vol. 6,1 (2021): 100. doi: https://doi.org/10.1038/s41525-021-00269-7
Levy MA, Beck DB, Metcalfe K, Douzgou S, Sithambaram S, Cottrell T, Ansar M, Kerkhof J, Mignot C, Nougues MC, Keren B, Moore HW, Oegema R, Giltay JC, Simon M, van Jaarsveld RH, Bos J, van Haelst M, Motazacker MM, Boon EMJ, Santen GWE, Ruivenkamp CAL, Alders M, Luperchio TR, Boukas L, Ramsey K, Narayanan V, Schaefer GB, Bonasio R, Doheny KF, Stevenson RE, Banka S, Sadikovic B, Fahrner JA. Author Correction: Deficiency of TET3 leads to a genome-wide DNA hypermethylation episignature in human whole blood. NPJ Genom Med. 2021 Nov 24;6(1):100. doi: 10.1038/s41525-021-00269-7. PMID: 34819528; PMCID: PMC8613275.
Copy Download .nbib Format: NLM
Showing 25 to 31 of 31 entries